FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies
- 10 January 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 44 (2) , 129
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic CarcinomaJournal of Clinical Oncology, 2025
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisThe Lancet Oncology, 2016